Finoriq research workspace
XBiotech Inc. (XBIT) SEC Filings & Filing Highlights
XBiotech Inc., a biopharmaceutical company, discovers, and develops, True Human monoclonal. Review XBIT SEC filings, filing highlights, and disclosure activity on Finoriq.
Company Snapshot
XBiotech Inc., a biopharmaceutical company, discovers, and develops, True Human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.
- Company
- XBiotech Inc. (XBIT)
- Ticker
- XBIT
- Market Cap
- $68.6M
- Latest Price
- $2.2501
- Industry
- Biotech & Pharma
XBiotech Inc. (XBIT) Recent SEC Filing Highlights
Recent SEC filings, filing events, and disclosure highlights indexed for XBiotech Inc. (XBIT).
| Event | Form | Date |
|---|---|---|
| XBiotech, Inc. (“XBiotech” or the “Company”) announces that John Simard notified members of the...XBiotech, Inc. (“XBiotech” or the “Company”) announces that John Simard notified members of the Board of Directors beginning on December 5,... | 8-K5.02 | 2025-12-09 |
| On October 2, 2025, John Simard and XBiotech, Inc. (the “Company”) entered into an Executive Em...On October 2, 2025, John Simard and XBiotech, Inc. (the “Company”) entered into an Executive Employment Agreement (the “Agreement”), with a... | 8-K5.02 | 2025-10-03 |
| Entry into a Definitive Material AgreementEntry into a Definitive Material Agreement | 8-K1.01 | 2025-10-03 |
| Proposal #1 Election of five members of the Board of DirectorsThe annual meeting of the stockholders of XBiotech Inc. (the “Company”) was held on August 29, 2025. The matters that were voted upon at th... | 8-K5.07 | 2025-09-02 |
| XBiotech Inc. (“XBiotech” or the “Company”) announces the June 24, 2025 appointments of Dr. Tho...XBiotech Inc. (“XBiotech” or the “Company”) announces the June 24, 2025 appointments of Dr. Thomas Kündig and Craig Rademaker to the Compan... | 8-K5.02 | 2025-06-24 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.